Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
304.9 USD | +1.29% | -0.44% | +5.72% |
May. 28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
May. 28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.